297 related articles for article (PubMed ID: 32835306)
1. Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
Pizzorno A; Padey B; Julien T; Trouillet-Assant S; Traversier A; Errazuriz-Cerda E; Fouret J; Dubois J; Gaymard A; Lescure FX; Dulière V; Brun P; Constant S; Poissy J; Lina B; Yazdanpanah Y; Terrier O; Rosa-Calatrava M
Cell Rep Med; 2020 Jul; 1(4):100059. PubMed ID: 32835306
[TBL] [Abstract][Full Text] [Related]
2. Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses
Stone NE; Jaramillo SA; Jones AN; Vazquez AJ; Martz M; Versluis LM; Raniere MO; Nunnally HE; Zarn KE; Nottingham R; Ng KR; Sahl JW; Wagner DM; Knudsen S; Settles EW; Keim P; French CT
mBio; 2021 Jan; 12(1):. PubMed ID: 33468703
[TBL] [Abstract][Full Text] [Related]
3. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.
Acharya A; Pandey K; Thurman M; Klug E; Trivedi J; Sharma K; Lorson CL; Singh K; Byrareddy SN
J Virol; 2021 Nov; 95(24):e0143721. PubMed ID: 34550770
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
Choi SW; Shin JS; Park SJ; Jung E; Park YG; Lee J; Kim SJ; Park HJ; Lee JH; Park SM; Moon SH; Ban K; Go YY
Antiviral Res; 2020 Dec; 184():104955. PubMed ID: 33091434
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.
Jang Y; Shin JS; Lee MK; Jung E; An T; Kim UI; Kim K; Kim M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557278
[TBL] [Abstract][Full Text] [Related]
8. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M
Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro.
Raymonda MH; Ciesla JH; Monaghan M; Leach J; Asantewaa G; Smorodintsev-Schiller LA; Lutz MM; Schafer XL; Takimoto T; Dewhurst S; Munger J; Harris IS
Virology; 2022 Jan; 566():60-68. PubMed ID: 34871905
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
Pizzorno A; Padey B; Dubois J; Julien T; Traversier A; Dulière V; Brun P; Lina B; Rosa-Calatrava M; Terrier O
Antiviral Res; 2020 Sep; 181():104878. PubMed ID: 32679055
[TBL] [Abstract][Full Text] [Related]
11. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
[TBL] [Abstract][Full Text] [Related]
12. On the molecular structure of Remdesivir for the treatment of Covid-19.
Sheikholeslami SM; Jahanbani A; Shao Z
Comput Methods Biomech Biomed Engin; 2021 Jul; 24(9):995-1002. PubMed ID: 33356621
[TBL] [Abstract][Full Text] [Related]
13. ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.
Posch W; Vosper J; Zaderer V; Noureen A; Constant S; Bellmann-Weiler R; Lass-Flörl C; Wilflingseder D
mBio; 2021 Apr; 12(2):. PubMed ID: 33906927
[TBL] [Abstract][Full Text] [Related]
14. Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection.
Monteil V; Dyczynski M; Lauschke VM; Kwon H; Wirnsberger G; Youhanna S; Zhang H; Slutsky AS; Hurtado Del Pozo C; Horn M; Montserrat N; Penninger JM; Mirazimi A
EMBO Mol Med; 2021 Jan; 13(1):e13426. PubMed ID: 33179852
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
Mulay A; Konda B; Garcia G; Yao C; Beil S; Villalba JM; Koziol C; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR
Cell Rep; 2021 May; 35(5):109055. PubMed ID: 33905739
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of itraconazole against SARS-CoV-2.
Van Damme E; De Meyer S; Bojkova D; Ciesek S; Cinatl J; De Jonghe S; Jochmans D; Leyssen P; Buyck C; Neyts J; Van Loock M
J Med Virol; 2021 Jul; 93(7):4454-4460. PubMed ID: 33666253
[TBL] [Abstract][Full Text] [Related]
17. Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir.
Pohl MO; Busnadiego I; Marrafino F; Wiedmer L; Hunziker A; Fernbach S; Glas I; Moroz-Omori EV; Hale BG; Caflisch A; Stertz S
J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34319869
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum stress and NF-kB activation in SARS-CoV-2 infected cells and their response to antiviral therapy.
Bartolini D; Stabile AM; Vacca C; Pistilli A; Rende M; Gioiello A; Cruciani G; Galli F
IUBMB Life; 2022 Jan; 74(1):93-100. PubMed ID: 34390301
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effects of human placenta hydrolysate (Laennec
Kim EH; Kim YI; Jang SG; Im M; Jeong K; Choi YK; Han HJ
J Microbiol; 2021 Nov; 59(11):1056-1062. PubMed ID: 34613605
[TBL] [Abstract][Full Text] [Related]
20. Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture.
Bakovic A; Risner K; Bhalla N; Alem F; Chang TL; Weston WK; Harness JA; Narayanan A
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
